2018
DOI: 10.1007/s11060-018-03018-6
|View full text |Cite
|
Sign up to set email alerts
|

Functional relevance of genes predicted to be affected by epigenetic alterations in atypical teratoid/rhabdoid tumors

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
7
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
8
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 10 publications
(7 citation statements)
references
References 40 publications
0
7
0
Order By: Relevance
“…We found Snr1 is needed for the transition from neuroepithelial cells into neuroblasts, as well as for neuroblast differentiation. These transitions are regulated by multiple pathways ( Apitz and Salecker, 2014 ), and Snr1 has been shown to regulate the expression of a large number of genes ( Tegeder et al, 2019 ). Comparative single cell RNA-sequencing (scRNA-seq) of the entire Drosophila central brain and optic lobes was used to identify the likely targets of Snr1 that are important for guiding these transitions ( Fig.…”
Section: Resultsmentioning
confidence: 99%
“…We found Snr1 is needed for the transition from neuroepithelial cells into neuroblasts, as well as for neuroblast differentiation. These transitions are regulated by multiple pathways ( Apitz and Salecker, 2014 ), and Snr1 has been shown to regulate the expression of a large number of genes ( Tegeder et al, 2019 ). Comparative single cell RNA-sequencing (scRNA-seq) of the entire Drosophila central brain and optic lobes was used to identify the likely targets of Snr1 that are important for guiding these transitions ( Fig.…”
Section: Resultsmentioning
confidence: 99%
“…Hu et al [43] reported that PRDM16 transforming megakaryocyte-erythroid progenitors into myeloid leukemia stem cells. In another study, PRDM16 knockdown induced cell proliferation in rhabdoid tumor cells [44], suggesting that PRDM16 may be an oncogene in leukemia development, although in other tumor types PRDM16 has a controversial role [45,46]. Thus, the role of PRDM16 in cancer biology has been poorly studied and remains to be fully elucidated.…”
Section: Discussionmentioning
confidence: 99%
“…Weighted gene expression network analysis has defined PRDM16 among the hub genes in renal cell carcinoma with an effect on patient survival suggesting it might be considered as a novel candidate biomarker of this malignancy [260]. Additionally, PRDM16 is highly overexpressed also in atypical teratoid/rhabdoid tumor, a highly malignant brain tumor predominantly arising in infants; moreover, it could have a functional role in human rhabdoid tumor cells since PRDM16 knockdown resulted in reduced metabolic activity and proliferation [261]. A different approach identified PRDM16 as a possible therapeutic target in PC.…”
Section: Prdm16mentioning
confidence: 99%